About: Micreos

An Entity of Type: agent, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Micreos is a Netherlands-based phage- and endolysin technology development company. The company is the developer of Staphefekt, an endolysin that selectively kills Staphylococcus aureus bacteria. The substance is an ingredient in the firm's skincare brand Gladskin which targets inflammatory skin conditions.

Property	Value
dbo:abstract	Micreos is a Netherlands-based phage- and endolysin technology development company. The company is the developer of Staphefekt, an endolysin that selectively kills Staphylococcus aureus bacteria. The substance is an ingredient in the firm's skincare brand Gladskin which targets inflammatory skin conditions. Micreos has developed phage- and endolysin-based products against specific bacteria such as Listeria, Salmonella and MRSA. Listex is their antimicrobial processing aid used to prevent Listeria in food products including meat, fish and cheese. The USDA, Health Canada, and FSANZ have approved these uses. Salmonelex, aimed at prevention of cross contamination and the killing of undesirable Salmonella bacteria on food during processing - has been approved as a GRAS processing aid by the FDA. Mark Offerhaus serves as the company’s CEO. (en)
dbo:foundingYear	2005-01-01 (xsd:gYear)
dbo:industry	dbr:Biotechnology
dbo:locationCountry	dbr:Netherlands
dbo:numberOfEmployees	50 (xsd:nonNegativeInteger)
dbo:product	dbr:Staphefekt
dbo:wikiPageExternalLink	http://www.micreos.com/
dbo:wikiPageID	40647424 (xsd:integer)
dbo:wikiPageLength	3821 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	948774762 (xsd:integer)
dbo:wikiPageWikiLink	dbc:2005_establishments_in_the_Netherlands dbr:Methicillin-resistant_Staphylococcus_aureus dbr:United_States_Department_of_Agriculture dbr:Staphylococcus_aureus dbc:Biotechnology_companies_of_the_Netherlands dbr:Food_Standards_Australia_New_Zealand dbr:Food_and_Drug_Administration dbr:Health_Canada dbr:Bacteriophage dbr:Staphefekt dbc:Companies_based_in_The_Hague dbr:Biotechnology dbr:Salmonella dbc:Biotechnology_companies_established_in_2005 dbr:Endolysin dbr:Netherlands dbr:Listeria
dbp:founded	2005 (xsd:integer)
dbp:founders	Mark Offerhaus & Hans-Poul Veldhuyzen van Zanten (en)
dbp:hqLocationCountry	dbr:Netherlands
dbp:industry	dbr:Biotechnology
dbp:name	Micreos (en)
dbp:numEmployees	50 (xsd:integer)
dbp:products	(en) Listex (en) Salmonelex (en) Staphefekt Products (en)
dbp:wikiPageUsesTemplate	dbt:Infobox_company dbt:Netherlands-company-stub dbt:Reflist
dcterms:subject	dbc:2005_establishments_in_the_Netherlands dbc:Biotechnology_companies_of_the_Netherlands dbc:Companies_based_in_The_Hague dbc:Biotechnology_companies_established_in_2005
rdf:type	owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 yago:WikicatBiotechnologyCompanies yago:WikicatCompaniesOfTheNetherlands yago:Abstraction100002137 yago:Company108058098 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation yago:SocialGroup107950920
rdfs:comment	Micreos is a Netherlands-based phage- and endolysin technology development company. The company is the developer of Staphefekt, an endolysin that selectively kills Staphylococcus aureus bacteria. The substance is an ingredient in the firm's skincare brand Gladskin which targets inflammatory skin conditions. (en)
rdfs:label	Micreos (en)
owl:sameAs	freebase:Micreos yago-res:Micreos wikidata:Micreos https://global.dbpedia.org/id/frxf
prov:wasDerivedFrom	wikipedia-en:Micreos?oldid=948774762&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:Micreos
foaf:name	Micreos (en)
is dbo:wikiPageRedirects of	dbr:Micreos_(company)
is dbo:wikiPageWikiLink of	dbr:Staphefekt dbr:Micreos_(company)
is foaf:primaryTopic of	wikipedia-en:Micreos